[Gen-Streitfall] United States Asks WTO to Set Up Panel To Rule in Dispute With Europe Over GMOs
Wiebke Herding
mail at wiebkeherding.de
Fr Aug 8 09:30:54 CEST 2003
International Trade Daily
Friday, August 8, 2003
ISSN 1533-1350
Lead Report
Agriculture
United States Asks WTO to Set Up Panel To Rule in Dispute With Europe
Over GMOs
The United States announced Aug. 7 that it is asking the World Trade
Organization to set up a dispute settlement panel to rule on its
complaint that the European Union has "illegally" halted approvals of
genetically modified organisms (GMOs) for the past five years.
Officials said that the United States, which initiated the complaint
last May, held formal consultations with the EU in June under WTO
rules but that the EU showed no willingness to lift the moratorium on
biotech products.
U.S. Trade Representative Robert B. Zoellick, announcing the U.S.
decision, said that the EU has left the United States with no choice
but to proceed with the establishment of a WTO panel.
"For five years," Zoellick said, "the EU has kept in place a ban on
biotech approvals--a ban which is unsupported even by the EU's own
scientific studies. This trade barrier harms farmers and consumers
around the world by denying them the benefits of productive,
nutritious, and environmentally friendly biotech products."
U.S. Agriculture Secretary Ann M. Veneman said that the United States
has been "extremely patient" with the EU.
"We have had exhaustive discussions with the Europeans," she said,
"and it now is time to let the dispute settlement process work."
The United States, along with Canada and Argentina, launched the case
May 13 by requesting formal WTO consultations.
U.S. officials said that Canada and Argentina were also requesting
WTO panels to consider the EU moratorium.
Dispute settlement procedures, including appeal, typically take about
18 months to play out.
The United States has argued that prior to 1999 the EU approved nine
agriculture biotech products for planting or import but then
suspended consideration of all new applications for approval without
offering any scientific evidence for moratorium--as required under
WTO rules.
A press release issued by USTR said that the adoption by the EU last
month of two new regulations on biotech products will have no effect
on the U.S. challenge to the moratorium on GMO approvals at the WTO.
One regulation will require that biotech products be traced
throughout the commercial chain, and that food containing biotech
products comply with certain labeling requirements.
The other regulation will provide for new approval procedures for
biotech food and feed products upon its entry into force in about six
months.
"Since neither one of these new regulations lifts the illegal
moratorium on biotech products," USTR said, "they do not affect the
U.S. WTO challenge."
By Gary G. Yerkey
Copyright © 2003 by The Bureau of National Affairs, Inc., Washington
D.C.
**********************************
In accordance with Title 17 U.S.C. Section 107, this material is
distributed without profit to those who have expressed a prior
interest in receiving the included information for research and
educational purposes.
Mehr Informationen über die Mailingliste Gen-Streitfall